General Information of the Compound
Compound ID
CP0518716
Compound Name
N'-(1H-benzimidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)but-2-yne-1,4-diamine
    Show/Hide
Structure
Formula
C21H23N5
Molecular Weight
345.45
Canonical SMILES
NCC#CCN(Cc1nc2ccccc2[nH]1)C1CCCc2cccnc12
    Show/Hide
InChI
InChI=1S/C21H23N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,5,7,11-12,14-15,22H2,(H,24,25)
    Show/Hide
InChIKey
ZQXRSZGLCHGNLB-UHFFFAOYSA-N
Physicochemical Property
logP
2.7996
Rotatable Bonds
4
Heavy Atom Count
26
Polar Areas
70.83
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10215423
SID: 15214433
ChEMBL ID
CHEMBL1089846
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02059, C-X-C chemokine receptor type 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000108 CCRF-CEM Homo sapiens (Human)  1
1
IC50 = 973 nM
   TI
   LI
   LO
   TS